Differences in Metabolic Factors Between Antipsychotic-Induced Weight Gain and Non-pharmacological Obesity in Youths-Reference-Cited by-同舟云学术

Differences in Metabolic Factors Between Antipsychotic-Induced Weight Gain and Non-pharmacological Obesity in Youths

Published:2018-02-12 Issue:5 Volume:38 Page:457-462
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Pisano Simone^ORCID,Coppola Giangennaro,Catone Gennaro,Carotenuto Marco,Iuliano Raffaella,D’Esposito Vittoria,Cabaro Serena,Miraglia del Giudice Emanuele,Bravaccio Carmela,Formisano Pietro

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/article/10.1007/s40261-018-0627-3/fulltext.html

Reference27 articles.

1. Olfson M, King M, Schoenbaum M. Treatment of young people with antipsychotic medications in the United States. JAMA Psychiatry. 2015;72:867–74.

2. Pozzi M, Cattaneo D, Baldelli S, Fucile S, Capuano A, Bravaccio C, Sportiello L, Bertella S, Auricchio F, Bernardini R, Ferrajolo C, Guastella G, Mani E, Carnovale C, Pisano S, Rafaniello C, Riccio MP, Rizzo R, Scuderi MG, Sperandeo S, Villa L, Pascotto A, Molteni M, Rossi F, Radice S, Clementi E. Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settings. Eur J Clin Pharmacol. 2016;72:285–93.

3. Pozzi M, Pisano S, Bertella S, Capuano A, Rizzo R, Antoniazzi S, Auricchio F, Carnovale C, Cattaneo D, Ferrajolo C, Gentili M, Guastella G, Mani E, Rafaniello C, Riccio MP, Scuderi MG, Sperandeo S, Sportiello L, Villa L, Radice S, Clementi E, Rossi F, Pascotto A, Bernardini R, Molteni M, Bravaccio C. Persistence in therapy with risperidone and aripiprazole in pediatric outpatients: a 2-year naturalistic comparison. J Clin Psychiatry. 2016;77:e1601–9.

4. Rafaniello C, Pozzi M, Pisano S, Ferrajolo C, Bertella S, Sportiello L, Carnovale C, Sullo MG, Cattaneo D, Gentili M, Rizzo R, Pascotto A, Mani E, Villa L, Riccio MP, Sperandeo S, Bernardini R, Bravaccio C, Clementi E, Molteni M, Rossi F, Radice S, Capuano A. Second generation antipsychotics in ‘real-life’ paediatric patients: adverse drug reactions and clinical outcomes of drug switch. Expert Opin Drug Saf. 2016;15:1–8.

5. Kryzhanovskaya LA, Xu W, Millen BA, Acharya N, Jen KY, Osuntokun O. Comparison of long-term (at least 24 weeks) weight gain and metabolic changes between adolescents and adults treated with olanzapine. J Child Adolesc Psychopharmacol. 2012;22:157–65.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors, prevention and treatment of weight gain associated with the use of antidepressants and antipsychotics: a state-of-the-art clinical review;Expert Opinion on Drug Safety;2024-09-03

2. Association Between Antidepressants and Antianxiety Medications and Weight Gain in Korean Adults Aged 19 to 39 Years;The Journal of Clinical Endocrinology & Metabolism;2024-08-06

3. Metabolic effects of atypical antipsychotics: Molecular targets;Journal of Neuroendocrinology;2023-10-22

4. Umbrella Review: Association Between Antipsychotic Drugs and Metabolic Syndrome Hallmarks in Children and Adolescents;Journal of the American Academy of Child & Adolescent Psychiatry;2023-06

5. Pharmacological Treatments and Natural Biocompounds in Weight Management;Pharmaceuticals;2023-01-30